NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1: Organization and Basis of Presentation
Semtech Corporation (together with its consolidated subsidiaries, the "Company" or "Semtech") is a leading global supplier of high-performance analog and mixed-signal semiconductors and advanced algorithms. The end customers for the Company’s products are primarily original equipment manufacturers ("OEMs") that produce and sell electronics.
The Company designs, develops and markets a wide range of products for commercial applications, the majority of which are sold into the infrastructure, high-end consumer and industrial end markets.
Basis of Presentation
The Company reports results on the basis of 52 and 53-week periods and ends its fiscal year on the last Sunday in January. Fiscal years 2022, 2021 and 2020 consisted of 52 weeks, 53 weeks and 52 weeks, respectively.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The Company’s Consolidated Statements of Income are referred to herein as the "Statements of Income," the Company’s Consolidated Balance Sheets are referred to herein as the "Balance Sheets" and the Company's Consolidated Statements of Cash Flows are referred to herein as the "Statements of Cash Flows." In the opinion of the Company, all adjustments of a normal and recurring nature necessary for a fair presentation, in all material respects, of the consolidated financial statements have been made. All intercompany balances have been eliminated. The Company consolidates entities that are not variable interest entities ("VIEs") when it owns, directly or indirectly, a majority interest in the entity or is otherwise able to control the entity. The Company consolidates VIEs in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 810, "Consolidation." Entities for which the Company owns an interest, but does not consolidate, are accounted for under the equity method or cost method of accounting as minority investments and are included in “Other Assets” within the Balance Sheets. The ownership interest in a consolidated subsidiary of the Company held by outside parties is included in “Noncontrolling Interest” within the Balance Sheets.
Use of Estimates
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Note 2: Significant Accounting Policies
Cash and Cash Equivalents
The Company considers all highly-liquid investments with an original maturity of 90 days or less and money market mutual funds to be cash equivalents. The Company maintains cash balances and cash equivalents in highly-qualified financial institutions. At various times, such amounts are in excess of insured limits. Cash equivalents can consist of money market mutual funds, government and corporate obligations, and bank time deposits.
Investments
The Company’s investment policy restricts investments to high credit quality investments with limits on the length to maturity and requires diversification of investment portfolio. These investments, especially corporate obligations, are subject to default risk. The Company classifies its convertible debt investments as available-for-sale ("AFS") securities and reports these investments at fair value with current and long-term AFS investments included in "Other current assets" and "Other assets," respectively, in the Balance Sheets. Unrealized gains or losses, net of tax, are recorded in "Accumulated other comprehensive income (loss)" in the Balance Sheets, and realized gains or losses, as well as current expected credit loss reserves are recorded in "Non-operating income, net" in the Statements of Income.
The Company has minority equity investments in privately-held companies that are classified in "Other assets" in the Balance Sheets. Substantially all of these investments are carried at cost because the Company does not have the ability to exercise significant influence over the companies. These minority equity investments do not have readily determinable fair values and the Company has determined that it is not practicable to estimate the fair values of these investments. As of January 30, 2022 and January 31, 2021, the Company had aggregate net investments carried at cost of $31.5 million and $24.1 million, respectively. As of January 30, 2022 and January 31, 2021, aggregate net investments accounted for under the equity method of accounting totaled $6.0 million and $3.1 million, respectively. The Company monitors whether there have been any events or changes in circumstances that would have a significant adverse effect on the fair values of these investments and recognizes losses in the Statements of Income when it determines that declines in the fair values of its investments below their cost are other than temporary. The Company recorded investment impairments and credit loss reserves of $1.3 million, $6.8 million and $1.2 million during fiscal years 2022, 2021 and 2020, respectively.
Accounts Receivable Allowances
Accounts receivable are recorded at net realizable value or the amount that the Company expects to collect on gross customer trade receivables. The Company evaluates the collectability of its accounts receivable based on a combination of factors. The Company generally does not require collateral on accounts receivable as the majority of the Company’s customers are large, well-established companies. Historically, bad debt provisions have been consistent with management’s expectations. If the Company becomes aware of a customer’s inability to meet its financial obligations after a sale has occurred, it records an allowance to reduce the net receivable to the amount it reasonably believes it will be able to collect from the customer. For all other customers, the Company recognizes allowances for doubtful accounts based on the length of time the receivables are past due, the current business environment and historical experience. If the financial condition of the Company’s customers were to deteriorate or if economic conditions worsen, additional allowances may be required in the future. All of the Company’s accounts receivables are trade-related receivables.
Inventories
Inventories are stated at lower of cost or net realizable value and consist of materials, labor, and overhead. The Company determines the cost of inventory by the first-in, first-out method. The Company evaluates inventories for excess quantities and obsolescence. This evaluation includes analysis of sales levels by product and projections of future demand. If future demand or market conditions are less favorable than the Company’s projections, a write-down of inventory may be required, and would be reflected in cost of goods sold in the period the revision is made. In order to state the inventory at lower of cost or net realizable value, the Company maintains reserves against inventory to write down its inventory on a part-by-part basis, if required.
Business Combinations
The Company accounts for business combinations in accordance with ASC 805, “Business Combinations.” The Company allocates the purchase price paid for assets acquired and liabilities assumed in connection with acquisitions based on their estimated fair values at the time of acquisition. This allocation involves a number of assumptions, estimates and judgments that could materially affect the timing or amounts recognized in its financial statements. The most subjective areas include determining the fair values of the following:
•intangible assets, including the valuation methodology, estimations of future cash flows, discount rates, market segment growth rates and the Company's assumed market segment share, as well as the estimated useful life of intangible assets;
•deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date;
•inventory; property, plant and equipment; pre-existing liabilities or legal claims; deferred revenue; and contingent consideration, each as may be applicable; and
•goodwill as measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed.
The Company’s assumptions and estimates are based upon comparable market data and information obtained from management and the management of the acquired companies. The Company allocates goodwill to the reporting units of the business that are expected to benefit from the business combination.
Variable Interest Entities
The Company consolidates VIEs in accordance with ASC 810, "Consolidation," if it is the primary beneficiary of the VIE, which is determined if it has a controlling financial interest in the VIE. A controlling financial interest will have both of the following characteristics: (i) the power to direct the VIE's activities that most significantly impact the VIE's economic performance and (ii) the obligation to absorb the VIE's losses that could potentially be significant to the VIE or the right to receive the VIE's benefits that could potentially be significant to the VIE.
The Company’s variable interests in VIEs may be in the form of equity ownership, contracts to purchase assets, management services, and development agreements between the Company and a VIE, loans provided by the Company to a VIE or other member, and/or guarantees provided by members to banks and other parties.
The Company analyzes its investments or other interests to determine whether it represents a variable interest in a VIE. If so, the Company evaluates the facts to determine whether it is the primary beneficiary, based on if it has a controlling financial interest in the VIE. The Company concluded that some of its equity interests represent a variable interest, but it is not the primary beneficiary as prescribed in ASC 810. Specifically, in reaching this conclusion, the Company considered the activities that most significantly drive profitability for these private entities and determined that the activities that most significantly drive profitability are related to the technology and related product road maps. In some cases, the Company has a board observer role, however, it concluded that in these cases it was not in a position of decision-making or other authority to influence the activities of the private entities that could be considered significant with respect to their operations, including research and development plans and changes to their product road maps.
Derivatives and Hedging Activities
The Company records all derivatives on the Balance Sheets at fair value in accordance with ASC 815, "Derivatives and Hedging." The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risks, even though hedge accounting does not apply or the Company elects not to apply hedge accounting.
In accordance with the FASB’s fair value measurement guidance, the Company made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
Property, Plant and Equipment
Property, plant and equipment are stated at cost or at fair market value at the time of acquisition. Depreciation is computed over the estimated useful lives of the related asset type or term of the operating lease using the straight-line method for financial statement purposes. Maintenance and repairs are charged to expense as incurred and the costs of additions and betterments that increase the useful lives of the assets are capitalized.
Goodwill
The Company performs an annual impairment assessment of goodwill at the reporting unit level in the fourth quarter of each fiscal year, or more frequently if indicators of potential impairment exist. The analysis may include both qualitative and quantitative factors to assess the likelihood of an impairment. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments and debt.
Qualitative factors include industry and market considerations, overall financial performance and other relevant events and factors affecting the reporting unit. Additionally, as part of this assessment, the Company may perform a quantitative analysis to support the qualitative factors above by applying sensitivities to assumptions and inputs used in measuring a reporting unit’s fair value.
The Company’s quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit's fair value. Significant estimates include market segment growth rates, assumed market segment share, estimated costs and discount rates based on a reporting unit's weighted average cost of capital.
The Company tests the reasonableness of the inputs and outcomes of its discounted cash flow analysis against available market data. As the fair values of all of the Company's reporting units exceeded their carrying values, no impairment of goodwill was recorded during fiscal years 2022, 2021 or 2020.
Other Intangibles and Long-lived Assets
Finite-lived intangible assets resulting from business acquisitions or technology licenses purchased are amortized on a straight-line basis over their estimated useful lives. The useful lives of acquisition-related intangible assets represent the point where over 90% of realizable undiscounted cash flows for each intangible asset are recognized. The assigned useful lives are based upon the Company’s historical experience with similar technology and other intangible assets owned by the Company. The useful life of technology licenses is usually based on the term of the agreement.
Acquired in-process research and development ("IPR&D") projects, which represent projects that had not reached technological feasibility as of the date of acquisition, are recorded at fair value. Initially, these are classified as an indefinite-lived intangible asset until the completion or abandonment of the associated research and development efforts. Upon completion of development, acquired IPR&D asset balances are transferred to finite-lived intangible assets and amortized over their useful lives. The asset balances relating to projects that are abandoned after acquisition are impaired and recorded in "Product development and engineering" ("R&D") expense in the Statements of Income.
The Company reviews indefinite-lived intangible assets for impairment on an annual basis in conjunction with goodwill or whenever events or changes in circumstances indicate that the carrying value may exceed its fair value. Impairment of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value.
The Company assesses finite-lived intangibles and long-lived assets for impairment when indicators of impairment, such as reductions in demand or significant industry and economic slowdowns in the semiconductor industry, are present. Reviews are performed to determine whether the carrying value of an asset is impaired, based on comparisons to undiscounted expected future cash flows. If this comparison indicates that there is impairment, the impaired asset is written down to fair value, which is typically calculated using: (i) quoted market price trends and internal factors such as changes in the Company's business strategy and/or (ii) discounted expected future cash flows utilizing a discount rate. Impairment is based on the excess of the carrying amount over the fair value of those assets the Company forecasts for specific product lines. Also, the Company reassesses the estimated remaining useful lives of any impaired assets and adjusts accordingly estimates of future amortization expense related to these assets.
For intangible long-lived assets, which consist of core technology and customer relationships, the Company uses the multi-period excess earnings method (an income approach) or the replacement cost method (a cost approach) to determine fair value. The multi-period excess earnings method estimates the value of the asset based on the present value of the after-tax cash flows attributable to the intangible asset, which includes the Company's estimates of forecasted revenue, operating margins, taxes, and discount rate. The replacement cost method incorporates a market participant’s assumption that an in-use premise is the highest and best use of customer relationships and core technology. The Company estimates the cost it would incur to rebuild or re-establish the intangible asset and the associated effort required to develop it.
The fair values of individual tangible long-lived assets are determined using the cost to reproduce the long-lived asset and taking into account the age, condition, inflation using the U.S. Bureau of Labor Statistics and Marshall Valuation Services, and cost to ready the long-lived asset for its intended use. Additionally, the Company considers the potential existence of functional and economic obsolescence and quantifies these elements in its cost approach as appropriate.
Functional Currency
The Company has concluded that the functional currency of all of its subsidiaries is the United States ("U.S.") Dollar.
Fair Value Measurements
When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. The Company uses the following three levels of inputs in determining the fair value of the Company’s assets and liabilities, focusing on the most observable inputs when available:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities in active markets or other inputs that are observable for the assets or liabilities, either directly or indirectly.
Level 3—Unobservable inputs based on the Company’s own assumptions, requiring significant management judgment or estimation.
To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed is determined based on the lowest level input that is significant to the fair value measurement.
Revenue Recognition
The Company derives its revenue primarily from the sale of semiconductor products into various end markets. Revenue is recognized in accordance with ASC 606, "Revenue from Contracts with Customers," when control of these products is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for these products. Control is generally transferred when products are shipped and, to a lesser extent, when the products are delivered. Recovery of costs associated with product design and engineering services are recognized during the period in which services are performed and are reported as a reduction to product development and engineering expense. Historically, these recoveries have not exceeded the cost of the related development efforts. The Company includes revenue related to granted technology licenses as part of "Net sales" in the Statements of Income. Historically, revenue from these arrangements has not been significant though they are part of its recurring ordinary business.
The Company determines revenue recognition through the following five steps:
•Identification of the contract, or contracts, with a customer;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, performance obligations are satisfied.
The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collectability of consideration is probable.
The Company’s revenue contracts generally represent a single performance obligation to sell its products to trade customers. Net sales reflect the transaction prices for contracts, which include units shipped at selling prices reduced by variable consideration. Determination of variable consideration requires judgment by the Company. Variable consideration includes expected sales returns and other price adjustments. Variable consideration is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Sales returns are generally accepted at the Company’s discretion or from distributors with such rights. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration.
The Company provides an assurance type warranty, which is typically not sold separately and does not represent a separate performance obligation.
Contract Modifications: If a contract is modified, which does not normally occur, changes in contract specifications and requirements must be accounted for. The Company considers contract modifications to exist when the modification creates new, or changes existing, enforceable rights and obligations. Most of the Company’s contract modifications are to distributor agreements for adding new goods or services that are considered distinct from the existing contract and the change in contract price reflects the standalone selling price of the distinct service.
Disaggregated Revenue: The Company disaggregates revenue from contracts with customers by types of products and geography, as it believes it best depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. See Note 15 for further information on revenues by product line and geographic region.
Contract Balances: Accounts receivable represents the Company’s unconditional right to receive consideration from its customers. Contract assets consist of the Company’s right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditioned on something other than the passage of time. ASC 606 also requires an entity to present a revenue contract as a contract liability in instances when a customer pays consideration, or an entity has a right to an amount of consideration that is unconditional (i.e., receivable), before the entity transfers a good or service to the customer. The Company's contract asset and contract liability balances were not material as of January 30, 2022
and January 31, 2021. There were no impairment losses recognized on the Company’s accounts receivable or contract assets during the fiscal year ended January 30, 2022.
Contract Costs: All incremental customer contract acquisition costs are expensed as they are incurred as the amortization period of the asset that the Company otherwise would have recognized is one year or less in duration.
Significant Financing Component: The Company does not adjust the promised amount of consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Sales Tax Exclusion from the Transaction Price: The Company excludes from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the Company from the customer.
Shipping and Handling Activities: The Company accounts for shipping and handling activities performed after a customer obtains control of the good as activities to fulfill the promise to transfer the good.
Cost of Sales
Cost of sales includes materials, depreciation on fixed assets used in the manufacturing process, shipping costs, direct labor and overhead.
Sales and Marketing
The Company expenses sales and marketing costs, which include advertising costs, as they are incurred. Advertising costs were $1.8 million, $1.0 million and $0.9 million for fiscal years 2022, 2021 and 2020, respectively.
Product Development and Engineering
Product development and engineering costs are charged to expense as incurred. Recoveries from nonrecurring engineering services are recorded as an offset to product development expense incurred in support of this effort since these activities do not represent an earnings process core to the Company’s business and serve as a mechanism to partially recover development expenditures. The Company received approximately $7.5 million, $9.6 million and $8.4 million of recoveries for nonrecurring engineering services in fiscal years 2022, 2021 and 2020, respectively.
Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts and their respective tax bases. Current and long-term prepaid taxes are included in "Prepaid taxes" and "Other assets," respectively, and current and long-term liabilities for uncertain tax positions are included in "Accrued liabilities" and "Other long-term liabilities," respectively, in the Balance Sheets.
As part of the process of preparing the Company’s consolidated financial statements, the Company estimates income taxes in each of the jurisdictions in which it operates. This process involves estimating the current tax liability together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities. The Company must assess the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent the Company believes that recovery is not likely, it must establish a valuation allowance. To the extent the Company changes its valuation allowance in a period, the change is generally recorded through the tax provision in the Statements of Income.
The Company continually reviews its position on undistributed earnings from its foreign subsidiaries to determine whether those earnings are indefinitely reinvested offshore. Domestic and foreign operating cash flow forecasts are reviewed to determine the sources and uses of cash. Based on these forecasts, the Company determines the need to accrue deferred tax liabilities associated with its undistributed offshore earnings.
Other Comprehensive Income (Loss)
Other comprehensive income or loss includes unrealized gains or losses on AFS investments, foreign currency and interest rate hedging activities, and changes in defined benefit plans, which are presented in the Statements of Comprehensive Income.
The following table summarizes the changes in other comprehensive income (loss) by component:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
(in thousands) | Pre-tax Amount | | Tax Benefit (Expense) | | Net Amount | | Pre-tax Amount | | Tax (Expense) Benefit | | Net Amount | | Pre-tax Amount | | Tax Benefit (Expense) | | Net Amount |
Defined benefit plans: | | | | | | | | | | | | | | | | | |
Other comprehensive income (loss) before reclassifications | $ | 1,792 | | | $ | (217) | | | $ | 1,575 | | | $ | (2,879) | | | $ | (469) | | | $ | (3,348) | | | $ | (9,237) | | | $ | 1,276 | | | $ | (7,961) | |
Amounts reclassified to earnings included in "Selling, general and administrative" | 2,722 | | | (421) | | | 2,301 | | | 2,901 | | | 461 | | | 3,362 | | | 3,446 | | | (476) | | | 2,970 | |
Foreign currency hedge: | | | | | | | | | | | | | | | | | |
Other comprehensive income (loss) before reclassifications | — | | | — | | | — | | | 780 | | | (178) | | | 602 | | | 66 | | | (7) | | | 59 | |
Amounts reclassified to earnings included in "Selling, general and administrative" | — | | | — | | | — | | | (780) | | | 178 | | | (602) | | | (149) | | | 16 | | | (133) | |
Interest rate hedge: | | | | | | | | | | | | | | | | | |
Other comprehensive income (loss) before reclassifications | 1,064 | | | (229) | | | 835 | | | (2,320) | | | 499 | | | (1,821) | | | — | | | — | | | — | |
Amounts reclassified to earnings included in "Interest expense" | 948 | | | (204) | | | 744 | | | 538 | | | (116) | | | 422 | | | — | | | — | | | — | |
Available-for-sale securities: | | | | | | | | | | | | | | | | | |
Other comprehensive income before reclassifications | 813 | | | (175) | | | 638 | | | 165 | | | (25) | | | 140 | | | 3,156 | | | (650) | | | 2,506 | |
Amounts reclassified to earnings included in "Non-operating income, net" | — | | | — | | | — | | | (939) | | | 182 | | | (757) | | | — | | | — | | | — | |
Other comprehensive income (loss) | $ | 7,339 | | | $ | (1,246) | | | $ | 6,093 | | | $ | (2,534) | | | $ | 532 | | | $ | (2,002) | | | $ | (2,718) | | | $ | 159 | | | $ | (2,559) | |
Accumulated Other Comprehensive Loss
The following table summarizes the changes in accumulated other comprehensive loss by component:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in thousands) | Defined Benefit Plans | | Foreign Currency Hedge | | Interest Rate Hedge | | Available-for-Sale Securities | | Cumulative Translation Adjustment | | Accumulated Other Comprehensive Loss |
Balance as of January 27, 2019 | $ | (4,511) | | | $ | 74 | | | $ | — | | | $ | — | | | $ | 830 | | | $ | (3,607) | |
Other comprehensive (loss) income | (4,991) | | | (74) | | | — | | | 2,506 | | | — | | | (2,559) | |
Balance as of January 26, 2020 | (9,502) | | | — | | | — | | | 2,506 | | | 830 | | | (6,166) | |
Other comprehensive income (loss) | 14 | | | — | | | (1,399) | | | (617) | | | — | | | (2,002) | |
Balance as of January 31, 2021 | (9,488) | | | — | | | (1,399) | | | 1,889 | | | 830 | | | (8,168) | |
Other comprehensive income (loss) | 3,876 | | | — | | | 1,579 | | | 638 | | | — | | | 6,093 | |
Balance as of January 30, 2022 | $ | (5,612) | | | $ | — | | | $ | 180 | | | $ | 2,527 | | | $ | 830 | | | $ | (2,075) | |
Share-Based Compensation
The Company has various equity award plans ("Plans") that provide for granting share-based awards to employees and non-employee directors of the Company. The Plans provide for the granting of several available forms of stock compensation such as non-qualified stock option awards ("NQSOs"), restricted stock unit awards ("RSUs") and equity awards with certain market conditions.
The Company measures compensation cost for all share-based payments at fair value on the measurement date, which is typically the grant date. RSUs are valued based on the stock price on the measurement date, while NQSOs are valued using the Black-Scholes pricing model, which considers, among other things, estimates and assumptions on the expected life of options, stock price volatility and market value of the Company's common stock. Additionally, for awards with a market condition, the Company uses a Monte Carlo simulation model to estimate grant date fair value, which takes into consideration the range of possible stock price or total stockholder return outcomes. In accordance with ASC 718, "Compensation—Stock Compensation," the Company recognizes forfeitures as they occur.
Earnings per Share
The computation of basic and diluted earnings per share was as follows:
| | | | | | | | | | | | | | | | | | | | |
| | Fiscal Year Ended |
(in thousands, except per share data) | | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Net income attributable to common stockholders | | $ | 125,664 | | | $ | 59,903 | | | $ | 31,871 | |
| | | | | | |
Weighted-average shares outstanding–basic | | 64,662 | | 65,208 | | 66,263 |
Dilutive effect of share-based compensation | | 903 | | | 851 | | 1,155 | |
Weighted-average shares outstanding–diluted | | 65,565 | | 66,059 | | 67,418 |
| | | | | | |
Earnings per share: | | | | | | |
Basic | | $ | 1.94 | | | $ | 0.92 | | | $ | 0.48 | |
Diluted | | $ | 1.92 | | | $ | 0.91 | | | $ | 0.47 | |
| | | | | | |
Anti-dilutive shares not included in the above calculations | | 35 | | | 406 | | | 120 | |
Basic earnings per share is computed by dividing income available to common stockholders by the weighted-average number of shares of common stock outstanding during the reporting period. Diluted earnings per share incorporates the incremental shares issuable, calculated using the treasury stock method, upon the assumed exercise of NQSOs and the vesting of RSUs and performance unit awards if certain conditions have been met, but excludes such incremental shares that would have an anti-dilutive effect.
Contingencies
From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. The Company is also subject to income tax, indirect tax or other tax claims by tax agencies in jurisdictions in which it conducts business. In addition, the Company is a party to environmental matters including local, regional, state, and federal government clean-up activities at or near locations where the Company currently or has in the past conducted business. The Company is required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of reasonably possible losses. A determination of the amount of reserves required for these commitments and contingencies that would be charged to earnings, if any, includes assessing the probability of adverse outcomes and estimating the amount of potential losses. The required reserves, if any, may change due to new developments in each matter or changes in circumstances such as a change in settlement strategy.
From time to time, the Company may record contingent earn-out liabilities, which represent the Company’s requirement to make additional payments related to acquisitions based on certain performance targets achieved during the earn-out periods. The Company measures contingent earn-out liabilities at fair value on a recurring basis using significant unobservable inputs classified within Level 3 of the fair value hierarchy. The significant unobservable inputs used in the fair value measurements are revenue projections over the earn-out period (or other specified performance targets) and the probability outcome percentages assigned to each scenario. Significant increases or decreases to either of these inputs in isolation would result in a significantly higher or lower liability, with a higher liability capped by the contractual maximum of the contingent earn-out obligation.
Recently Adopted Accounting Guidance
In December 2019, the FASB issued Accounting Standards Update ("ASU") No. 2019-12, "Simplifying the Accounting for Income Taxes," which modifies ASC 740 to simplify the accounting for income taxes. This guidance impacts the accounting for hybrid tax regimes, the tax basis step-up in goodwill obtained in a transaction that is not a business combination, separate financial statements of legal entities not subject to tax, the intraperiod tax allocation exception to the incremental approach, ownership changes in investments from a subsidiary to an equity method investment and vice versa, interim period accounting for enacted changes in tax law and the year-to-date loss limitation in interim period tax accounting. This guidance is effective for fiscal years beginning after December 15, 2020, and interim periods within this those fiscal years, with early adoption permitted. The Company adopted this guidance in the first quarter of fiscal year 2022. Adoption of this guidance did not have a material impact on the Company's consolidated financial statements.
Accounting Guidance Issued, but not yet Adopted as of January 30, 2022
In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistencies related to recognition of an acquired contract liability, and to payment terms and their effect on subsequent revenue recognized by the acquirer. Among other changes, this ASU requires that an acquirer account for acquired revenue contracts in accordance with ASC 606, "Revenue from Contracts with Customers," as if it had originated the contracts. If the acquirer is unable to assess or rely on how the acquiree applied ASC 606, the acquirer should consider the terms of the acquired contracts as of the contract inception or contract modification date in applying ASC 606 to determine what should be recorded at the acquisition date. The amendments also provide certain practical expedients for acquirers when recognizing and measuring acquired contract assets and contract liabilities from revenue contracts in a business combination. The guidance is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company does not expect the adoption of this guidance to have a material impact on its consolidated financial statements.
Note 3: Available-for-sale securities
The following table summarizes the values of the Company’s AFS securities:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| January 30, 2022 | | January 31, 2021 |
(in thousands) | Fair Value | | Amortized Cost | | Gross Unrealized Gain/(Loss) | | Fair Value | | Amortized Cost | | Gross Unrealized Gain/(Loss) |
Convertible debt | $ | 12,872 | | | $ | 14,401 | | | $ | (1,529) | | | $ | 11,989 | | | $ | 13,244 | | | $ | (1,255) | |
Total available-for-sale securities | $ | 12,872 | | | $ | 14,401 | | | $ | (1,529) | | | $ | 11,989 | | | $ | 13,244 | | | $ | (1,255) | |
The following table summarizes the maturities of the Company’s AFS securities:
| | | | | | | | | | | | | | | |
| January 30, 2022 | | |
(in thousands) | Fair Value | | Amortized Cost | | | | |
Within 1 year | $ | 10,582 | | | $ | 10,856 | | | | | |
After 1 year through 5 years | 2,290 | | | 3,545 | | | | | |
Total available-for-sale securities | $ | 12,872 | | | $ | 14,401 | | | | | |
The Company's AFS securities consist of investments in convertible debt instruments issued by privately-held companies. The AFS investments with maturities within one year were included in "Other current assets" and with maturities greater than one year were included in "Other assets" in the Balance Sheets.
Note 4: Fair Value Measurements
Instruments Measured at Fair Value on a Recurring Basis
The fair values of financial assets and liabilities measured and recorded at fair value on a recurring basis were presented in the Balance Sheets as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| January 30, 2022 | | January 31, 2021 |
(in thousands) | Total | | (Level 1) | | (Level 2) | | (Level 3) | | Total | | (Level 1) | | (Level 2) | | (Level 3) |
Financial assets: | | | | | | | | | | | | | | | |
Interest rate swap agreement | $ | 229 | | | $ | — | | | $ | 229 | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | | | | |
Convertible debt | 12,872 | | | — | | | — | | | 12,872 | | | 11,989 | | | — | | | — | | | 11,989 | |
| | | | | | | | | | | | | | | |
Total financial assets | $ | 13,101 | | | $ | — | | | $ | 229 | | | $ | 12,872 | | | $ | 11,989 | | | $ | — | | | $ | — | | | $ | 11,989 | |
| | | | | | | | | | | | | | | |
Financial liabilities: | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Interest rate swap agreement | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 1,782 | | | $ | — | | | $ | 1,782 | | | $ | — | |
Total return swap contracts | 257 | | | — | | | 257 | | | — | | | 167 | | | — | | | 167 | | | — | |
Total financial liabilities | $ | 257 | | | $ | — | | | $ | 257 | | | $ | — | | | $ | 1,949 | | | $ | — | | | $ | 1,949 | | | $ | — | |
During the fiscal year ended January 30, 2022, the Company had no transfers of financial assets or liabilities between Level 1 or Level 2. As of January 30, 2022 and January 31, 2021, the Company had not elected the fair value option for any financial assets and liabilities for which such an election would have been permitted.
The convertible debt investments are valued utilizing a combination of estimates that are based on the estimated discounted cash flows associated with the debt and the fair value of the equity into which the debt may be converted, all of which are Level 3 inputs.
The following table presents a reconciliation of the changes in convertible debt investments in the fiscal year ended January 30, 2022:
| | | | | |
(in thousands) | |
Balance at January 31, 2021 | $ | 11,989 | |
Additions | 722 | |
| |
Fair market value adjustment to OCI | 813 | |
Increase in credit loss reserve | (1,087) | |
Interest accrued | 1,061 | |
Conversion to equity | (626) | |
Balance at January 30, 2022 | $ | 12,872 | |
The interest rate swap agreement is measured at fair value using readily available interest rate curves (Level 2 inputs). The fair value of the agreement is determined by comparing, for each settlement, the contract rate to the forward rate and discounting to the present value. Contracts in a gain position are recorded in "Other current assets" and "Other assets" in the Balance Sheets and the value of contracts in a loss position are recorded in "Accrued liabilities" and "Other long term liabilities" in the Balance Sheets. See Note 18 for further discussion of the Company's derivative instruments.
The total return swap contracts are measured at fair value using quoted prices of the underlying investments (Level 2 inputs). The fair values of the total return swap contracts are recognized in the Balance Sheets in "Accrued Liabilities" if the instruments are in a loss position and in "Other Current Assets" if the instruments are in a gain position. See Note 18 for further discussion of the Company's derivative instruments.
Instruments Not Recorded at Fair Value on a Recurring Basis
Some of the Company’s financial instruments are not measured at fair value on a recurring basis, but are recorded at amounts that approximate fair value due to their liquid or short-term nature. Such financial assets and financial liabilities include: cash and cash equivalents including money market deposits, net receivables, certain other assets, accounts payable, accrued expenses, accrued personnel costs, and other current liabilities. The Company’s long-term debt is recorded at cost, which approximates fair value as the long-term debt bears interest at a floating rate.
Assets and Liabilities Recorded at Fair Value on a Non-Recurring Basis
The Company reduces the carrying amounts of its goodwill, intangible assets, long-lived assets, and non-marketable equity securities to fair value when held for sale or determined to be impaired.
Investment Impairments and Credit Loss Reserves
The total credit loss reserve for the Company's held-to-maturity debt securities and AFS debt securities was $4.5 million and $3.4 million as of January 30, 2022 and January 31, 2021, respectively. During the fiscal year ended January 30, 2022, the Company increased its credit loss reserves by $1.1 million for its AFS debt securities and recorded a $0.2 million impairment on its non-marketable equity investments. During the fiscal year ended January 31, 2021, the Company increased its credit loss reserves by $2.9 million for its AFS debt securities and held-to-maturity debt securities due, in part, to the impact of the COVID-19 pandemic on early-stage development companies. In addition, during the fiscal year ended January 31, 2021, the Company recorded a $3.9 million impairment on its non-marketable equity investments.
Note 5: Inventories
Inventories, consisting of material, material overhead, labor, and manufacturing overhead, are stated at the lower of cost (first-in, first-out) or net realizable value and consisted of the following:
| | | | | | | | | | | |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Raw materials | $ | 4,304 | | | $ | 2,936 | |
Work in progress | 85,445 | | | 59,523 | |
Finished goods | 24,254 | | | 25,035 | |
Inventories | $ | 114,003 | | | $ | 87,494 | |
Note 6: Property, Plant and Equipment
The following is a summary of property and equipment:
| | | | | | | | | | | | | | | | | |
(in thousands) | Estimated Useful Lives | | January 30, 2022 | | January 31, 2021 |
Land | | | $ | 13,605 | | | $ | 13,605 | |
Buildings | 7 to 39 years | | 39,448 | | | 35,106 | |
Leasehold improvements | 2 to 10 years | | 11,741 | | | 9,271 | |
Machinery and equipment | 3 to 8 years | | 228,089 | | | 211,671 | |
Computer hardware and software | 3 to 13 years | | 74,815 | | | 71,306 | |
Furniture and office equipment | 5 to 7 years | | 6,637 | | | 5,692 | |
Construction in progress | | | 15,369 | | | 18,062 | |
Property, plant and equipment, gross | | | 389,704 | | | 364,713 | |
Less: accumulated depreciation and amortization | | | (254,764) | | | (233,779) | |
Property, plant and equipment, net | | | $ | 134,940 | | | $ | 130,934 | |
As of January 30, 2022 and January 31, 2021, construction in progress consisted primarily of machinery and equipment awaiting completion of installation and being placed in service.
Depreciation expense was $26.0 million, $23.6 million, and $23.4 million in fiscal years 2022, 2021, and 2020, respectively.
Note 7: Goodwill and Intangible Assets
Goodwill
The carrying amounts of goodwill by applicable reporting unit were as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
(in thousands) | Signal Integrity | | Wireless and Sensing | | Protection | | Total |
Balance at January 31, 2021 | $ | 274,085 | | | $ | 72,128 | | | $ | 4,928 | | | $ | 351,141 | |
| | | | | | | |
Balance at January 30, 2022 | $ | 274,085 | | | $ | 72,128 | | | $ | 4,928 | | | $ | 351,141 | |
Goodwill is not amortized, but is tested for impairment at the reporting unit level using either a qualitative or quantitative assessment on an annual basis during the fourth quarter of each fiscal year, and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Impairment of goodwill is measured at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill, to the fair market value of the reporting unit. The reporting units are the same as the operating segments, which have been aggregated into two reportable segments (see Note 15 on segment information). For fiscal years 2022 and 2021, the Company performed a qualitative assessment and concluded that it was more likely than not that the fair value of each of the three reporting units exceeded its carrying value. For fiscal year 2020, the Company performed a quantitative assessment that demonstrated that the fair value of the reporting units was higher than their respective carrying values. As of January 30, 2022 and January 31, 2021, there were no indications of impairment of the Company's goodwill balances, and no impairment to goodwill was recorded during fiscal years 2022, 2021 or 2020.
Purchased Intangibles
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and technology licenses purchased, which are amortized over their estimated useful lives:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | January 30, 2022 | | January 31, 2021 |
(in thousands) | Estimated Useful Life | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization | | Net Carrying Amount |
Core technologies | 6-8 years | | $ | 26,300 | | | $ | (19,496) | | | $ | 6,804 | | | $ | 29,300 | | | $ | (17,554) | | | $ | 11,746 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
Total finite-lived intangible assets | | | $ | 26,300 | | | $ | (19,496) | | | $ | 6,804 | | | $ | 29,300 | | | $ | (17,554) | | | $ | 11,746 | |
Amortization expense of finite-lived intangible assets, which was recorded in "Intangible Amortization" in the Statements of Income, was as follows:
| | | | | | | | | | | | | | | | | |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Core technologies | $ | 4,942 | | | $ | 7,676 | | | $ | 14,263 | |
Customer relationships | — | | | 589 | | | 2,283 | |
| | | | | |
| | | | | |
Total amortization expense | $ | 4,942 | | | $ | 8,265 | | | $ | 16,546 | |
Future amortization expense of finite-lived intangible assets is expected as follows:
| | | | | | | | | | | |
(in thousands) | | | | | | | |
To be recognized in: | | | | | | | Total |
Fiscal year 2023 | | | | | | | $ | 4,002 | |
Fiscal year 2024 | | | | | | | 1,676 | |
Fiscal year 2025 | | | | | | | 288 | |
Fiscal year 2026 | | | | | | | 288 | |
Fiscal year 2027 | | | | | | | 288 | |
Thereafter | | | | | | | 262 | |
Total expected amortization expense | | | | | | | $ | 6,804 | |
| | | | | | | |
Note 8: Accrued Liabilities
The following is a summary of accrued liabilities for fiscal years 2022 and 2021:
| | | | | | | | | | | |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Compensation | $ | 38,619 | | | $ | 29,397 | |
Deferred revenue | 13,047 | | | 3,923 | |
Refund liabilities | 11,036 | | | 9,351 | |
Lease liabilities | 3,977 | | | 3,975 | |
| | | |
| | | |
Deferred compensation | 1,966 | | | 1,709 | |
Professional fees | 1,838 | | | 2,525 | |
Environmental reserve | 640 | | | 531 | |
Earn-out liability | — | | | 1,958 | |
| | | |
| | | |
| | | |
| | | |
| | | |
Other | 6,581 | | | 6,015 | |
Total accrued liabilities | $ | 77,704 | | | $ | 59,384 | |
Note 9: Long-Term Debt
Long-term debt and the current period interest rates were as follows:
| | | | | | | | | | | |
(in thousands) | January 30, 2022 | | January 31, 2021 |
| | | |
Revolving loans | $ | 173,000 | | | $ | 181,000 | |
| | | |
| | | |
Debt issuance costs | (1,324) | | | (1,805) | |
Total long-term debt, net of debt issuance costs | $ | 171,676 | | | $ | 179,195 | |
Effective interest rate (1) | 1.90 | % | | 1.88 | % |
(1) The revolving loans bear interest at a variable rate based on LIBOR or a Base Rate, at the Company’s option, plus an applicable margin that varies based on the Company’s consolidated leverage ratio. In the first quarter of fiscal year 2021, the Company entered into an interest rate swap agreement that fixed the interest on the first $150.0 million of debt outstanding under the revolving loans at 1.9775%. As of January 30, 2022, the effective interest rate was a weighted-average rate that represented (a) interest on the first $150.0 million of the debt outstanding at a fixed LIBOR rate of 0.7275% plus a margin of 1.25% (total fixed rate of 1.9775%), and (b) interest on the remainder of the debt outstanding at a variable rate based on the one-month LIBOR rate, which was 0.11% as of January 30, 2022, plus a margin of 1.25% (total variable rate of 1.36%). As of January 31, 2021, the effective interest rate was a weighted average-rate that represented (a) interest on the first $150.0 million of the debt outstanding at a fixed LIBOR rate of 0.7275% plus a margin of 1.25% (total fixed rate of 1.9775%), and (b) interest on the remainder of the debt outstanding at a variable rate based on the one-month LIBOR rate, which was 0.14% as of January 31, 2021, plus a margin of 1.25% (total variable rate of 1.39%).
On November 7, 2019, the Company, with certain of its domestic subsidiaries as guarantors, entered into an amended and restated credit agreement (the "Credit Agreement") with the lenders party thereto and HSBC Bank USA, National Association, as administrative agent, swing line lender and letter of credit issuer. The borrowing capacity of the revolving loans under the senior secured first lien credit facility (the "Credit Facility") is $600.0 million and matures on November 7, 2024. Up to $40.0 million of the revolving loans may be used to obtain letters of credit, up to $25.0 million of the revolving loans may be used to obtain swing line loans, and up to $40.0 million of the revolving loans may be used to obtain revolving loans and letters of credit in certain currencies other than U.S. Dollars ("Alternative Currencies"). The proceeds of the Credit Facility may be used by the Company for capital expenditures, permitted acquisitions, permitted dividends, working capital and general corporate purposes. Proceeds of the Credit Facility were used to repay in full all of the obligations outstanding under the Company's then existing senior secured first lien credit facility and to pay transaction costs in connection with such refinancing.
The Credit Agreement provides that, subject to certain customary conditions, including obtaining commitments with respect thereto, the Company may request the establishment of one or more term loan facilities and/or increases to the revolving loans in a principal amount not to exceed (a) $300.0 million, plus (b) an unlimited amount, so long as the Company's consolidated leverage ratio, determined on a pro forma basis, does not exceed 3.00 to 1.00. However, the lenders are not required to provide such increase upon the Company's request.
On August 11, 2021, the Company entered into an amendment to the Credit Agreement in order to, among other things, (i) provide for contractual fallback language for LIBOR replacement to reflect the Alternative Reference Rates Committee hardwired approach and (ii) incorporate certain provisions that clarify the rights of the administrative agent to recover from lenders or other secured parties erroneous payments made to such lenders or secured parties.
In fiscal year 2021, the Company entered into an interest rate swap agreement with a three-year term to hedge the variability of interest payments on the first $150.0 million of debt outstanding under the Credit Facility. Interest payments on $150.0 million of the Company's debt are now fixed at 1.9775% based on the Company's current leverage ratio as of January 30, 2022. The Company's debt in excess of $150.0 million remains subject to a floating rate.
Interest on loans made under the Credit Agreement in U.S. Dollars accrues, at the Company's option, at a rate per annum equal to (1) the Base Rate (as defined below) plus a margin ranging from 0.25% to 1.25% depending upon the Company’s consolidated leverage ratio or (2) LIBOR (determined with respect to deposits in U.S. Dollars) for an interest period to be selected by the Company plus a margin ranging from 1.25% to 2.25% depending upon the Company's consolidated leverage ratio (such margin, the "Applicable Margin"). The "Base Rate" is equal to a fluctuating rate equal to the highest of (a) the prime rate of the Administrative Agent, (b) 0.50% above the federal funds effective rate published by the Federal Reserve Bank of New York and (c) one-month LIBOR (determined with respect to deposits in U.S. Dollars) plus 1.00%. Interest on loans made under the Credit Facility in Alternative Currencies accrues at a rate per annum equal to LIBOR (determined with respect to deposits in the applicable Alternative Currency) (other than loans made in Canadian Dollars, for which a special reference rate for Canadian Dollars applies) for an interest period to be selected by the Company plus the Applicable Margin.
Commitment fees on the unused portion of the revolving loans accrue at a rate per annum ranging from 0.20% to 0.35% depending upon the Company's consolidated leverage ratio. The Company's current commitment fee rate is 0.20% per annum.
With respect to letters of credit, the Company will pay the Administrative Agent, for the account of the Lenders, letter of credit participation fees at a rate per annum equal to the Applicable Margin then in effect with respect to LIBOR-based loans on the face amount of all outstanding letters of credit. The Company will also pay HSBC Bank USA, N.A., as the issuing bank, a
fronting fee for each letter of credit issued under the Credit Agreement at a rate equal to 0.125% per annum based on the maximum amount available to be drawn under each such letter of credit, as well as its customary documentation fees.
All obligations of the Company under the Credit Agreement are unconditionally guaranteed by all of the Company’s direct and indirect domestic subsidiaries, other than certain excluded subsidiaries, including, but not limited to, any domestic subsidiary the primary assets of which consist of equity or debt of non-U.S. subsidiaries, certain immaterial non-wholly-owned domestic subsidiaries and subsidiaries that are prohibited from providing a guarantee under applicable law or that would require governmental approval to provide such guarantee. The Company and the guarantors have also pledged substantially all of their assets to secure their obligations under the Credit Agreement.
No amortization is required with respect to the revolving loans and the Company may voluntarily prepay borrowings at any time and from time to time, without premium or penalty, other than customary "breakage costs" and fees for LIBOR-based loans.
The Credit Agreement contains customary covenants, including limitations on the Company’s ability to, among other things, incur indebtedness, create liens on assets, engage in certain fundamental corporate changes, make investments, repurchase stock, pay dividends or make similar distributions, engage in certain affiliate transactions, or enter into agreements that restrict the Company's ability to create liens, pay dividends or make loan repayments. In addition, the Company must comply with financial covenants, including maintaining a maximum consolidated leverage ratio, determined as of the last day of each fiscal quarter, of 3.50 to 1.00 or less, provided that, such maximum consolidated leverage ratio may be increased to 4.00 to 1.00 for the four consecutive fiscal quarters ending on or after the date of consummation of a permitted acquisition that constitutes a "Material Acquisition" under the Credit Agreement, subject to the satisfaction of certain conditions. As of January 30, 2022, the Company was in compliance with the covenants required under the Credit Agreement.
The Credit Agreement also contains customary provisions pertaining to events of default. If any event of default occurs, the obligations under the Credit Agreement may be declared due and payable, terminated upon written notice to the Company and existing letters of credit may be required to be cash collateralized.
The amendment of the Credit Agreement in fiscal year 2020 resulted in a loss on early extinguishment of debt totaling $0.5 million related to the write off of unamortized discounts and loan costs, which was presented in "Non-operating income, net" within the Statements of Income.
As of January 30, 2022, the Company had $173.0 million outstanding under its Credit Facility and $427.0 million of undrawn borrowing capacity.
Interest expense was comprised of the following components for the periods presented:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Contractual interest (1) | $ | 4,610 | | | $ | 4,854 | | | $ | 8,622 | |
Amortization of debt discount and issuance costs | 481 | | | 482 | | | 484 | |
Total interest expense | $ | 5,091 | | | $ | 5,336 | | | $ | 9,106 | |
(1) Contractual interest represents the interest on the Company's outstanding debt after giving effect to the interest rate swap agreement.
As of January 30, 2022, there were no amounts outstanding under the letters of credit, swing line loans and alternative currency sub-facilities.
Note 10: Share-Based Compensation
Financial Statement Effects and Presentation
Pre-tax share-based compensation was included in the Statements of Income for fiscal years 2022, 2021 and 2020 as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Cost of sales | $ | 2,901 | | | $ | 2,501 | | | $ | 1,928 | |
Selling, general and administrative | 32,578 | | | 37,000 | | | 38,556 | |
Product development and engineering | 15,710 | | | 13,485 | | | 11,565 | |
Share-based compensation | $ | 51,189 | | | $ | 52,986 | | | $ | 52,049 | |
| | | | | |
Restricted Stock Units, Employees
The Company grants restricted stock units to certain employees, which are expected to be settled with shares of the Company's common stock. The grant date for these awards is equal to the measurement date. These awards are valued as of the measurement date, based on the fair value of the Company's common stock at the grant date, and recognized as share-based compensation expense over the requisite vesting period (typically 4 years).
The following table is a summary of the status of nonvested restricted stock unit awards as of January 30, 2022, and changes during the year.
| | | | | | | | | | | | | | | |
| Restricted Stock Units, Stock Grants and Stock Units | | |
(in thousands, except per share data) | Shares | | Weighted-Average Grant Date Fair Value (per share) | | | | |
Nonvested at January 31, 2021 | 2,059 | | | $ | 50.39 | | | | | |
Granted | 755 | | | 67.91 | | | | | |
Vested | (805) | | | 47.30 | | | | | |
Forfeited | (107) | | | 53.63 | | | | | |
Nonvested at January 30, 2022 | 1,902 | | | $ | 58.47 | | | | | |
The aggregate unrecognized compensation for the non-vested restricted stock units as of January 30, 2022 was $88.5 million, which will be recognized over a weighted-average period of 2.5 years.
Restricted Stock Units, Non-Employee Directors
The Company maintains a compensation program pursuant to which restricted stock units are granted to the Company’s directors that are not employed by the Company or any of its subsidiaries. Under the Company's director compensation program, a portion of the stock units granted under the program would be settled in cash and a portion would be settled in shares of the Company's common stock. Restricted stock units awarded under the program are scheduled to vest on the earlier of (i) one year after the grant date or (ii) the day immediately preceding the annual meeting of stockholders in the year following the grant. The portion of a restricted stock unit award under the program that is to be settled in cash will, subject to vesting, be settled when the director who received the award separates from the board of directors. The portion of a restricted stock unit award under the program that is to be settled in shares of stock will, subject to vesting, be settled promptly following vesting. There were no changes to the terms and conditions of the existing awards.
The restricted stock units that are to be settled in cash are accounted for as liabilities. These awards are not typically settled until a non-employee director’s separation from service, so the value of both the unvested and vested but unsettled awards are re-measured at the end of each reporting period until settlement. As of January 30, 2022, the total number of vested, but unsettled awards was 174,414 units, and the $11.5 million liability associated with these awards was included in "Other long-term liabilities" in the Balance Sheets.
The restricted stock units that are to be settled in shares are accounted for as equity. The grant date for these awards is equal to the measurement date. These awards are valued as of the measurement date, based on the fair value of the Company's common stock at the grant date, and recognized as share-based compensation expense over the requisite vesting period (typically one year).
The following table summarizes the activity for the non-employee directors restricted stock units for the fiscal year ended January 30, 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
(in thousands, except per share data) | Total Units | | Units Subject to Share Settlement | | Units Subject to Cash Settlement | | Weighted-Average Grant Date Fair Value (per share) |
Nonvested at January 31, 2021 | 28 | | | 13 | | | 15 | | | $ | 51.52 | |
Granted | 24 | | | 12 | | | 12 | | | 68.06 | |
Vested | (28) | | | (13) | | | (15) | | | 51.52 | |
| | | | | | | |
Nonvested at January 30, 2022 | 24 | | | 12 | | | 12 | | | $ | 68.06 | |
Total Stockholder Return ("TSR") Market-Condition Restricted Stock Units
The Company grants TSR market-condition restricted stock units (the "TSR Awards") to certain executives of the Company, which are accounted for as equity awards. The TSR Awards have a pre-defined market condition, which determines the number of shares that ultimately vest, as well as a service condition. The TSR Awards are valued as of the grant date using a Monte Carlo simulation which takes into consideration the possible outcomes pertaining to the TSR market condition and expense is recognized on a straight-line basis over the requisite service periods and is adjusted for any actual forfeitures.
In fiscal years 2022, 2021 and 2020, the Company granted, 81,688, 137,224 and 266,000, respectively, of TSR Awards. The market condition is determined based upon the Company’s TSR benchmarked against the TSR of the S&P SPDR Semiconductor ETF (NYSE:XSD) over one, two and three year periods (one-third of the awards vesting each performance period). Generally, the TSR Awards recipients must be employed for the entire performance period and be an active employee at the time of vesting of the awards. The grant-date fair values per unit of the TSR Awards granted in fiscal year 2022 for each one, two and three-year performance periods were $67.41, $77.99 and $84.17, respectively.
The following table summarizes the activity for the TSR Awards for fiscal year 2022:
| | | | | | | | | | | |
(in thousands, except per share data) | Total Units | | Weighted-Average Grant Date Fair Value (per share) |
Nonvested at January 31, 2021 | 203 | | | $ | 49.62 | |
Granted | 82 | | | 76.52 | |
Vested | (16) | | | 67.41 | |
Cancelled/Forfeited (1) | (131) | | | 51.59 | |
| | | |
Nonvested at January 30, 2022 | 138 | | | $ | 61.61 | |
(1) Primarily represents cancellations due to awards not meeting the TSR target, as well as cancellations due to the retirement of an officer.
Amounts in the table above include the stated number of awards granted and outstanding. However, the number of awards that ultimately vest may be higher or lower than the originally granted amounts depending upon the actual TSR achievement level over the performance period. For example, of the 140,416 awards scheduled to vest on January 30, 2022, only 16,011 actually vested due to lower than target TSR achievement levels.
The aggregate unrecognized compensation expense for TSR Awards as of January 30, 2022, was $3.9 million, which will be recognized over a weighted-average period of 1.2 years.
Market-Condition Restricted Stock Units, Employees
In fiscal year 2022, the Company granted an additional 54,928 restricted stock units to certain executives of the Company, which have a different pre-defined market condition that determines the number of shares that ultimately vest. These additional awards are eligible to vest during the period commencing March 9, 2021, and ending March 5, 2024 (the "Performance Period") as follows: the restricted stock units covered by the award will vest if, during any consecutive 30 trading day period that commences and ends during the Performance Period, the average per-share closing price of the Company’s common stock equals or exceeds $95.00. The award will also vest at a pro-rata percentage of the unvested portion of the total restricted units if a majority change in control of the Company occurs during the Performance Period and, in connection with such event, the Company’s stockholders become entitled to receive per-share consideration having a value equal to or greater than $71.00 but less than $95.00. If the change in control per-share consideration is equal to or greater than $95.00 the award will fully vest. These market-condition restricted stock units are valued as of the grant date using a Monte Carlo simulation model and expense is recognized on a straight-line basis over the requisite service period and is adjusted for any actual forfeitures. The grant-date fair value per unit of the awards granted in fiscal year 2022 was $49.55. The aggregate compensation expense for the market-condition restricted stock units has been fully recognized as of January 30, 2022.
Market-Condition Restricted Stock Units, CEO
In fiscal year 2020, the Company granted its Chief Executive Officer ("CEO") 320,000 restricted stock units with a market condition. The award is eligible to vest during the period commencing March 5, 2019, and ending March 5, 2024 (the "Performance Period") as follows: 30% of the restricted stock units covered by the award will vest if, during any consecutive 30 day trading period that commences and ends during the Performance Period, the average per-share closing price of the Company’s common stock equals or exceeds $71.00 ("Tranche 1") and the award will vest in full if, during any consecutive 30 day trading period that commences and ends during the Performance Period, the average per-share closing price of the Company’s common stock equals or exceeds $95.00 ("Tranche 2"). The award will also vest as to 30% if a majority change in control of the Company occurs during the Performance Period and, in connection with such event, the Company’s stockholders become entitled to receive per-share consideration having a value equal to or greater than $71.00 but less than $95.00. If the change in control per-share consideration is equal to or greater than $95.00 the award will fully vest. The fair value of Tranche 1 and Tranche 2 at the grant date was determined to be $44.32 and $33.19, respectively, by application of the Monte Carlo simulation model. Expense is recognized on a straight-line basis over the requisite service periods and is adjusted for any actual forfeitures.
On January 8, 2021, the Company's 30 day average-per-share closing price met the threshold for Tranche 1 resulting in the vesting of 30%, or 96,000 units, of the original award. The aggregate compensation expense for the market-condition restricted stock units has been fully recognized as of January 30, 2022.
Non-Qualified Stock Options
In prior years, the Company has granted non-qualified stock options to both employees and non-employee directors. The fair value of these grants were measured on the grant date and recognized as expense over the requisite vesting period (typically 3-4 years). The Company used the Black-Scholes pricing model to value stock options. There were no stock options granted in fiscal years 2022, 2021 or 2020. The number of shares authorized per the equity incentive plan is 17,031,653, and the maximum contractual term of equity share options is generally ten years.
The following table summarizes the activity for stock options for fiscal year 2022:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(in thousands, except per share data) | Number of Shares | | Weighted- Average Exercise Price (per share) | | Aggregate Intrinsic Value (1) | | | | Number of Shares Exercisable | | Weighted-Average Contractual Term (years) |
Vested and expected to vest at January 31, 2021 | 335 | | | $ | 30.28 | | | $ | 13,627 | | | | | 238 | | |
| | | | | | | | | | | |
Exercised | (213) | | | 24.73 | | | 10,234 | | | | | | | |
Forfeited | (4) | | | 35.42 | | | | | | | | | |
Vested and expected to vest at January 30, 2022 | 118 | | | $ | 40.17 | | | $ | 3,253 | | | | | 84 | | 2.4 |
Vested and exercisable at January 30, 2022 | 84 | | | $ | 37.16 | | | $ | 2,579 | | | | | | | 2.3 |
| | | | | | | | | | | |
(1) The aggregate intrinsic value of stock options vested and exercisable and vested and expected to vest as of January 30, 2022 is calculated based on the difference between the exercise price and the $67.83 closing price of the Company's common stock as of January 30, 2022.
The aggregate unrecognized compensation expense for the outstanding stock options as of January 30, 2022 was $0.2 million, which will be recognized over a weighted-average period of 0.5 years.
The following table summarizes information regarding nonvested stock option awards at January 30, 2022:
| | | | | | | | | | | | | | | | | |
(in thousands, except per share data) | Number of Shares | | Weighted-Average Exercise Price (per share) | | Weighted-Average Grant Date Fair Value (per share) |
Nonvested at January 31, 2021 | 96 | | | $ | 44.80 | | | $ | 13.35 | |
| | | | | |
Vested | (61) | | | 43.21 | | | 12.76 | |
Forfeited | (1) | | | 45.13 | | | 13.36 | |
Nonvested at January 30, 2022 | 34 | | | $ | 47.73 | | | $ | 14.45 | |
Performance-Based Restricted Stock Units
Prior to fiscal year 2018, the Company granted performance-based restricted stock units to select employees. These awards had a performance condition in addition to a service condition. The performance metrics were based on a pre-defined cumulative three-year performance of the Company’s revenue and non-GAAP operating income measured against internal goals. For these awards, the performance was tied to the Company’s performance in the grant year and the succeeding two fiscal years. The performance award recipients must be employed for the entire three-year period, which is the explicit service and requisite service period, and be an active employee at the time of vesting of the awards (cliff vesting at the end of the third year). At January 27, 2019, the performance metrics associated with the remaining outstanding awards, which were issued in fiscal year 2017, were met at a level which resulted in a grant that vested at 180.8% of target. Under the terms of these awards, 187,116 shares were settled in shares and 187,116 shares were settled in cash in the amount of $9.3 million during fiscal year 2020. There are no remaining awards outstanding as of January 30, 2022.
Note 11: Income Taxes
The Company's regional income before income taxes and equity in net gains (losses) of equity method investments was as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Domestic | $ | (16,593) | | | $ | (26,170) | | | $ | (24,530) | |
Foreign | 155,662 | | | 89,145 | | | 69,115 | |
Total | $ | 139,069 | | | $ | 62,975 | | | $ | 44,585 | |
The provision for income taxes consisted of the following:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Current income tax provision (benefit) | | | | | |
Federal | $ | 1,078 | | | $ | 6,716 | | | $ | 6,463 | |
State | 211 | | | (69) | | | 100 | |
Foreign | 16,374 | | | 4,801 | | | 11,861 | |
Subtotal | 17,663 | | | 11,448 | | | 18,424 | |
Deferred income tax provision (benefit) | | | | | |
Federal | (1,797) | | | (7,012) | | | 74 | |
State | — | | | 20 | | | (33) | |
Foreign | (327) | | | (1,019) | | | (5,637) | |
Subtotal | (2,124) | | | (8,011) | | | (5,596) | |
Provision for income taxes | $ | 15,539 | | | $ | 3,437 | | | $ | 12,828 | |
The provision for income taxes reconciles to the amount computed by applying the statutory federal rate to income before taxes as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Federal income tax at statutory rate | $ | 29,194 | | | $ | 13,309 | | | $ | 9,328 | |
State income taxes, net of federal benefit | 272 | | | (186) | | | 68 | |
Foreign taxes differential, including withholding taxes | (6,611) | | | (2,688) | | | (966) | |
Tax credits generated | (9,008) | | | (4,361) | | | (2,026) | |
Changes in valuation allowance | 1,778 | | | (438) | | | (2,722) | |
Gain on intra-entity asset transfer | — | | | — | | | 6,802 | |
Changes in uncertain tax positions | 180 | | | 1,841 | | | 8,636 | |
| | | | | |
Equity compensation | (2,698) | | | (3,573) | | | (6,008) | |
| | | | | |
| | | | | |
GILTI and Subpart F income | 441 | | | 270 | | | 538 | |
Impact of U.S. tax reform | — | | | — | | | — | |
| | | | | |
| | | | | |
Other | 1,991 | | | (737) | | | (822) | |
Provision for income taxes | $ | 15,539 | | | $ | 3,437 | | | $ | 12,828 | |
The Company’s tax expense benefited from its operations in lower tax jurisdictions such as Switzerland, research tax credits and the recognition of excess tax benefits related to share-based compensation.
On December 6, 2016, the Company was granted a tax holiday ("Tax Holiday") with an effective date of January 30, 2017. The Tax Holiday provides Semtech (International) AG with a 70% reduction to the Swiss Cantonal tax rate, bringing the statutory Swiss Cantonal tax rate down from 12.56% to 3.77%. The maximum benefit under this Tax Holiday is CHF 500.0 million of cumulative after tax profit, which equates to a maximum potential tax savings of CHF 44.0 million. The Tax Holiday was effective for five years and could be extended for an additional five years if the Company met certain staffing targets by January 30, 2022. Semtech (International) AG has met these staffing guidelines, and therefore, the tax holiday is extended for an additional 5 years ending January 31, 2027.
On May 19, 2019, Switzerland approved the Federal Act on Tax Reform ("Swiss Tax Reform"). One main component of the Swiss Tax Reform included reduction of Cantonal income tax rates. The Swiss Tax Reform dropped the statutory Swiss Cantonal tax rate down from 12.56% to 8.46%. Semtech’s Tax Holiday provides Semtech (International) AG with a 70% reduction to this new Swiss Cantonal tax rate, bringing the statutory Swiss Cantonal tax rate down from 8.46% to 2.54%. All other provisions of the existing Tax Holiday discussed above still apply.
The Tax Act imposed a U.S. tax on global intangible low taxed income (“GILTI”) that is earned by certain foreign affiliates owned by a U.S. stockholder. In accordance with guidance issued by the FASB, the Company has made a policy election to treat future taxes related to GILTI as a current period expense in the reporting period in which the tax is incurred.
Prior to the enactment of the Tax Act, with few exceptions, U.S. federal income and foreign withholding taxes had not been provided on the excess of the amount for financial reporting over the tax basis of investments in the Company’s foreign subsidiaries that were essentially permanent in duration. With the enactment of the Tax Act, all historic and current foreign earnings are taxed in the U.S. Depending on the jurisdiction, these foreign earnings are potentially subject to a withholding tax, if repatriated. As of January 30, 2022, our historical undistributed earnings of the Company’s foreign subsidiaries are intended to be permanently reinvested outside of the U.S.
Notwithstanding the U.S. taxation of these amounts, we have determined that $50.0 million of our current foreign earnings will not be permanently reinvested. As a result, we have established a deferred income tax liability for the Swiss withholding tax that will be due upon distribution of these earnings. If we needed to remit all or a portion of our historical undistributed earnings to the U.S. for investment in our domestic operations, any such remittance could result in increased tax liabilities and a higher effective tax rate. Determination of the amount of the unrecognized deferred tax liability on these unremitted earnings is not practicable.
The components of the net deferred income tax assets and liabilities at January 30, 2022 and January 31, 2021 were as follows:
| | | | | | | | | | | |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Non-current deferred tax assets: | | | |
| | | |
Inventory reserve | $ | 5,734 | | | $ | 4,435 | |
Bad debt reserve | 26 | | | 23 | |
| | | |
Foreign tax credits | 3,304 | | | 1,974 | |
Research credit carryforward | 13,498 | | | 9,700 | |
NOL carryforward | 7,839 | | | 7,659 | |
Payroll and related accruals | 11,743 | | | 10,248 | |
Share-based compensation | 5,256 | | | 5,822 | |
Foreign pension deferred | 1,412 | | | 2,020 | |
Accrued sales reserves | 1,012 | | | 464 | |
Research and development charges | 7,263 | | | 4,005 | |
Goodwill and other intangibles | — | | | 690 | |
Leasing deferred assets | 4,311 | | | 3,573 | |
Other deferred assets | 2,239 | | | 3,253 | |
Valuation allowance | (17,506) | | | (15,751) | |
Total non-current deferred tax assets | 46,131 | | | 38,115 | |
Non-current deferred tax liabilities: | | | |
| | | |
Goodwill and other intangibles | (1,530) | | | — | |
Property, plant and equipment | (6,990) | | | (6,820) | |
Repatriation of foreign earnings | (4,709) | | | (2,538) | |
Leasing deferred liabilities | (4,139) | | | (3,415) | |
Other non-current deferred tax liabilities | (2,093) | | | (835) | |
Total non-current deferred tax liabilities | (19,461) | | | (13,608) | |
Net deferred tax assets | $ | 26,670 | | | $ | 24,507 | |
As of January 30, 2022, the Company had U.S. state net operating loss carryforwards of $103.5 million, which, subject to certain limitations, are available to offset future taxable income through fiscal year 2042.
As of January 30, 2022, the Company had U.S. gross federal and state research credits available of approximately $13.3 million and $15.7 million, respectively, which are available to offset taxable income. These credits will expire between fiscal years 2029 through 2042. The Company also had gross Canadian research credits available of approximately $6.7 million. These credits will expire by fiscal year 2042.
As of January 30, 2022 and January 31, 2021, the Company had approximately $44.1 million and $40.3 million of net deferred tax assets, respectively, the majority of which are in the U.S. and Canada. The Company has recorded valuation allowances of $17.5 million and $15.8 million against its deferred tax assets at January 30, 2022 and January 31, 2021, respectively, based on the Company's assessment of its ability to utilize its deferred tax assets. The valuation allowances established relate to certain U.S. deferred tax assets, for which the Company has determined that it is more likely than not that a benefit will not be realized. In considering whether a valuation allowance was required for the Company's U.S. deferred income tax assets, the Company considered all available positive and negative evidence. Positive evidence considered included reversing taxable temporary differences. Negative evidence considered included the cumulative pre-tax losses in the U.S. recorded during the three-year period ended January 30, 2022, on both an annual and cumulative basis.
Changes in the valuation allowance for the three years ended January 30, 2022 are summarized in the table below:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Beginning balance | $ | 15,751 | | | $ | 16,189 | | | $ | 18,912 | |
Additions | 2,605 | | | 1,208 | | | 159 | |
Releases | (850) | | | (1,646) | | | (2,882) | |
Ending balance | $ | 17,506 | | | $ | 15,751 | | | $ | 16,189 | |
Uncertain Tax Positions
The Company uses a two-step approach to recognize and measure uncertain tax positions ("UTP"). The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate settlement.
A reconciliation of the beginning and ending amount of gross unrecognized tax benefits (before federal impact of state items) is as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Beginning balance | $ | 26,850 | | | $ | 25,466 | |
Net additions based on tax positions related to the current year | 925 | | | 400 | |
Additions based on tax positions related to prior years | 464 | | | 2,760 | |
Reductions as a result of lapsed statutes | (991) | | | (261) | |
Reductions for settlements with tax authorities | (197) | | | (1,515) | |
Ending balance | $ | 27,051 | | | $ | 26,850 | |
Included in the balance of gross unrecognized tax benefits at January 30, 2022 and January 31, 2021, are $9.3 million and $9.7 million, respectively, of net tax benefits (after federal impact of state items) that, if recognized, would impact the effective tax rate.
The liability for UTP is reflected on the Balance Sheets as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Deferred tax assets - non-current | $ | 16,346 | | | $ | 15,770 | |
| | | |
Other long-term liabilities | 9,335 | | | 9,731 | |
Total accrued taxes | $ | 25,681 | | | $ | 25,501 | |
The Company’s policy is to include net interest and penalties related to unrecognized tax benefits within the provision for taxes in the Statements of Income. The Company had approximately $1.3 million of net interest and penalties accrued at January 30, 2022.
Tax years prior to 2013 (the Company’s fiscal year 2014) are generally not subject to examination by the IRS except for items involving tax attributes that have been carried forward to tax years whose statute of limitations remains open. For state returns in the U.S., the Company is generally not subject to income tax examinations for years prior to 2012 (the Company’s fiscal year 2013). The Company has a significant tax presence in Switzerland for which Swiss tax filings have been examined through fiscal year 2020. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax examinations cannot be predicted with certainty. If any issues addressed in the Company’s tax examinations are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.
Note 12: Leases
The Company has operating leases for real estate, vehicles and office equipment, which are accounted for in accordance with ASC 842, "Leases." Real estate leases are used to secure office space for the Company's administrative, engineering, production support and manufacturing activities. The Company's leases have remaining lease terms of up to eight years, some of which include options to extend the leases for up to three years, and some of which include options to terminate the leases within one year.
The components of lease expense were as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Operating lease cost | $ | 5,704 | | | $ | 4,900 | |
Short-term lease cost | 1,070 | | | 1,037 | |
| | | |
Less: sublease income | (141) | | | (132) | |
Total lease cost | $ | 6,633 | | | $ | 5,805 | |
Supplemental cash flow information related to leases was as follows:
| | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Cash paid for amounts included in the measurement of lease liabilities | $ | 5,639 | | | $ | 4,909 | |
Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 7,862 | | | $ | 9,209 | |
| | | |
| | | | | |
| As of |
| January 30, 2022 |
Weighted-average remaining lease term - operating leases (in years) | 5.59 |
Weighted-average discount rate on remaining lease payments - operating leases | 6.3 | % |
Supplemental balance sheet information related to leases was as follows:
| | | | | | | | | | | |
| Balance as of |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Operating lease right-of-use assets in "Other Assets" | $ | 19,777 | | | $ | 16,337 | |
| | | |
Operating lease liabilities in "Accrued Liabilities" | $ | 3,977 | | | $ | 3,975 | |
Operating lease liabilities in "Other long-term Liabilities" | 16,577 | | | 13,172 | |
Total operating lease liabilities | $ | 20,554 | | | $ | 17,147 | |
Maturities of lease liabilities as of January 30, 2022 are as follows:
| | | | | |
(in thousands) | |
Fiscal Year Ending: | |
2023 | $ | 5,097 | |
2024 | 4,602 | |
2025 | 4,447 | |
2026 | 3,451 | |
2027 | 2,234 | |
Thereafter | 4,602 | |
Total lease payments | 24,433 | |
Less: imputed interest | (3,879) | |
Total | $ | 20,554 | |
Note 13: Commitments and Contingencies
Unconditional Purchase Commitments
The following table presents the Company’s open capital commitments and other open purchase commitments for the purchase of plant, equipment, raw material, supplies and services as of January 30, 2022:
| | | | | | | | | | | | | | | | | |
(in thousands) | Less than 1 year | | 1-3 years | | Total |
Open capital purchase commitments | $ | 3,706 | | | $ | — | | | $ | 3,706 | |
Other open purchase commitments | 82,758 | | | 15,164 | | | 97,922 | |
| | | | | |
Total purchase commitments | $ | 86,464 | | | $ | 15,164 | | | $ | 101,628 | |
Legal Matters
In accordance with ASC 450-20, "Loss Contingencies," the Company accrues an undiscounted liability for those contingencies where the incurrence of a loss is probable and the amount can be reasonably estimated. The Company also discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if material. The Company does not record liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated, or when the liability is believed to be only reasonably possible or remote. The Company evaluates, at least quarterly, developments in its legal matters that could affect the amount of liability that has been previously accrued, and makes adjustments as appropriate. Significant judgment is required to determine both probability and the estimated amount. The Company may be unable to estimate a possible loss or range of possible loss due to various reasons, including, among others: (i) if the damages sought are indeterminate, (ii) if the proceedings are in early stages, (iii) if there is uncertainty as to the outcome of pending appeals, motions or settlements, (iv) if there are significant factual issues to be determined or resolved, and (v) if there are novel or unsettled legal theories presented. In such instances, there is considerable uncertainty regarding the ultimate resolution of such matters, including a possible eventual loss, if any.
Because the outcomes of litigation and other legal matters are inherently unpredictable, the Company’s evaluation of legal matters or proceedings often involves a series of complex assessments by management about future events and can rely heavily on estimates and assumptions. While the consequences of certain unresolved matters and proceedings are not presently determinable, and an estimate of the probable and reasonably possible loss or range of loss in excess of amounts accrued for such proceedings cannot be reasonably made, an adverse outcome from such proceedings could have a material adverse effect on the Company’s earnings in any given reporting period. However, in the opinion of management, after consulting with legal counsel, any ultimate liability related to current outstanding claims and lawsuits, individually or in the aggregate, is not expected to have a material adverse effect on the Company’s consolidated financial statements, as a whole. However, legal matters are inherently unpredictable and subject to significant uncertainties, some of which are beyond the Company’s control.
As such, even though the Company intends to vigorously defend itself with respect to its legal matters, there can be no assurance that the final outcome of these matters will not materially and adversely affect the Company’s business, financial condition, operating results, or cash flows.
From time to time, the Company is involved in various claims, litigation, and other legal actions that are normal to the nature of its business, including with respect to IP, contract, product liability, employment, and environmental matters. In the opinion of management, after consulting with legal counsel, any ultimate liability related to current outstanding claims and lawsuits, individually or in the aggregate, is not expected to have a material adverse effect on the Company’s consolidated financial statements, as a whole.
Environmental Matters
The Company vacated a former facility in Newbury Park, California in 2002, but continues to address groundwater and soil contamination at the site. The Company’s efforts to address site conditions have been at the direction of the Los Angeles Regional Water Quality Control Board (“RWQCB”). In October 2013, an order was issued including a scope of proposed additional site work, monitoring and remediation activities. The Company has been complying with RWQCB orders and direction, and continues to implement an approved remedial action plan addressing the soil, groundwater and soil vapor at the site.
The Company has accrued liabilities where it is probable that a loss will be incurred and the cost or amount of loss can be reasonably estimated. Based on the latest determinations by the RWQCB and the most recent actions taken pursuant to the remedial action plan, the Company estimates the range of probable loss between $7.4 million and $8.0 million. To date, the Company has made $5.7 million in payments towards the remedial action plan and, as of January 30, 2022, has a remaining accrual of $1.7 million related to this matter. Given the uncertainties associated with environmental assessment and the remediation activities, the Company is unable to determine a best estimate within the range of loss. Therefore, the Company has
recorded the minimum amount of probable loss. These estimates could change as a result of changes in planned remedial actions, further actions from the regulatory agency, remediation technology and other factors.
Indemnification
The Company has entered into agreements with its current and former executives and directors indemnifying them against certain liabilities incurred in connection with the performance of their duties. The Company’s Certificate of Incorporation and Bylaws also contain indemnification obligations with respect to the Company’s current directors and employees.
Product Warranties
The Company’s general warranty policy provides for repair or replacement of defective parts. In some cases, a refund of the purchase price is offered. In certain instances the Company has agreed to other or additional warranty terms, including indemnification provisions.
The product warranty accrual reflects the Company’s best estimate of probable liability under its product warranties. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated, and accrues for estimated incurred but unidentified issues based on historical experience. Historically, warranty expense and the related accrual has been immaterial to the Company’s consolidated financial statements.
Retirement Plans
The Company contributed $1.4 million, $1.2 million and $1.2 million in fiscal years 2022, 2021 and 2020, respectively, to the 401(k) retirement plan maintained for its employees based in the U.S.
In addition, the Company also contributed $0.8 million, $0.7 million and $0.8 million in fiscal years 2022, 2021 and 2020, respectively, to a defined contribution plan for its employees in Canada.
The Company has defined benefit pension plans for the employees of its Swiss subsidiaries (the "Swiss Plans"), which it accounts for in accordance with ASC 715-30, "Defined Benefit Plans – Pension." The Swiss Plans provide government-mandated retirement, death and disability benefits. Under the Swiss Plans, the Company and its employees make government-mandated minimum contributions. Minimum contributions are based on the respective employee’s age, salary and gender. As of January 30, 2022 and January 31, 2021, the Swiss Plans had an unfunded net pension obligation of approximately $10.6 million and $13.9 million, respectively, plan assets of approximately $42.8 million and $36.3 million, respectively, and projected benefit obligation of approximately $53.4 million and $50.2 million, respectively. For fiscal years 2022 and 2021, net periodic pension expense was $1.7 million and $2.4 million, respectively, and contributions made by the Company were $1.9 million and $1.6 million, respectively.
The Company records a post-retirement benefit for the employees of its French subsidiary (the "French Plan"), which it accounts for in accordance with ASC 715-30. The French Plan is defined by the collective bargaining agreement of R&D, IT and consulting firms. Minimum contributions are based on the respective years of service for all permanent employees. As of January 30, 2022, the French Plan had an unfunded net pension obligation of approximately $0.4 million, plan assets of zero and projected benefit obligation of approximately $0.4 million. As of January 31, 2021, the French Plan had an unfunded net pension obligation of approximately $0.4 million, plan assets of zero and a projected benefit obligation of approximately $0.4 million. For fiscal years 2022 and 2021, net periodic pension expense was $0.4 million and $0.1 million, respectively, and contributions made by the Company were $0.5 million and $0.6 million, respectively.
Deferred Compensation
The Company maintains a deferred compensation plan for certain officers and key executives that allows participants to defer a portion of their compensation for future distribution at various times permitted by the plan. This plan provides for a discretionary Company match up to a defined portion of the employee’s deferral, with any match subject to a defined vesting schedule.
Under this plan, the Company incurred expense, net of forfeitures, of $2.7 million, $7.0 million and $6.8 million in fiscal years 2022, 2021 and 2020, respectively. For fiscal years 2022 and 2021, these net expenses include $1.5 million and $0.3 million, respectively, of net gains resulting from total return swap contracts used to hedge the market risk associated with the unfunded portion of the deferred compensation liability. See Note 18 for further discussion of the Company's derivative instruments.
The Company’s liability for the deferred compensation plan is presented below:
| | | | | | | | | | | |
(in thousands) | January 30, 2022 | | January 31, 2021 |
Accrued liabilities | $ | 1,966 | | | $ | 1,709 | |
Other long-term liabilities | 43,197 | | | 39,299 | |
Total deferred compensation liabilities under this plan | $ | 45,163 | | | $ | 41,008 | |
The Company has purchased whole life insurance on the lives of certain current deferred compensation plan participants. This corporate-owned life insurance is held in a grantor trust and is intended to cover a majority of the Company’s costs of the deferred compensation plan. The cash surrender value of the corporate-owned life insurance was $35.2 million and $27.6 million as of January 30, 2022 and January 31, 2021, respectively, and is included in "Other assets" in the Balance Sheets. The increase in the cash surrender value of the corporate-owned life insurance as of January 30, 2022 compared to January 31, 2021 was related to an overall increase in market value and $6.0 million of premiums paid in order to provide substantive coverage for the Company's deferred compensation liability. Changes in the cash surrender value of the corporate-owned life insurance resulted in net gains of $1.6 million, $3.3 million and $3.8 million in fiscal years 2022, 2021 and 2020, respectively.
Earn-out Liability
Pursuant to the terms of an amended earn-out arrangement ("Cycleo Earn-out") with the former shareholders of Cycleo SAS ("Cycleo Earn-out Beneficiaries"), which the Company acquired in March 2012, earn-out payments were based on the achievement of a combination of certain sales and operating income milestones over the period of April 27, 2015 to April 26, 2020. For certain of the Cycleo Earn-out Beneficiaries, payment of the earn-out liability was contingent upon continued employment and was accounted for as post-acquisition compensation expense over the service period. The portion of the earn-out liability that was not dependent on continued employment was not considered as compensation expense. During fiscal year 2022, payments made related to the final earn-out milestone totaled $1.4 million. At January 30, 2022, the Cycleo Earn-out liability balance was zero, compared to a balance at January 31, 2021 of $2.0 million, which included $1.7 million of compensation expense and $0.3 million not contingent upon continued employment.
Note 14: Concentration of Risk
The following significant customers accounted for at least 10% of the Company's net sales in one or more of the periods indicated:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(percentage of net sales) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Frontek Technology Corporation (and affiliates) | 18 | % | | 16 | % | | 11 | % |
Trend-tek Technology Ltd. (and affiliates) | 17 | % | | 17 | % | | 13 | % |
| | | | | |
CEAC International Ltd. (and affiliates) | 11 | % | | 11 | % | | 8 | % |
Arrow Electronics (and affiliates) | 10 | % | | 9 | % | | 9 | % |
Premier Technical Sales Korea, Inc. (and affiliates) (1) | 6 | % | | 6 | % | | 7 | % |
Samsung Electronics (and affiliates) | 2 | % | | 2 | % | | 4 | % |
| | | | | |
(1) Premier is a distributor with a concentration of sales to Samsung Electronics (and affiliates). The above percentages represent the Company's estimate of the sales activity related to Samsung Electronics (and affiliates) that is passing through this distributor.
The following table shows the customers that have an outstanding receivable balance that represents at least 10% of the Company's total net receivables as of one or more of the dates indicated:
| | | | | | | | | | | |
(percentage of net receivables) | January 30, 2022 | | January 31, 2021 |
| | | |
Frontek Technology Corporation (and affiliates) | 17 | % | | 10 | % |
CEAC International Ltd. (and affiliates) | 10 | % | | 14 | % |
Trend-tek Technology Ltd. (and affiliates) | 7 | % | | 14 | % |
| | | |
For fiscal years 2022, 2021 and 2020, authorized distributors accounted for approximately 87%, 82% and 72%, respectively, of the Company’s net sales. Generally, the Company does not have long-term contracts with its distributors and most can terminate their agreement with little or no notice. For fiscal year 2022, the Company's largest distributors were based in Asia.
Outside Subcontractors and Suppliers
The Company relies on a limited number of third-party subcontractors and suppliers for the production of silicon wafers, packaging and certain other tasks. Disruption or termination of supply sources or subcontractors, including due to the COVID-19 pandemic or natural disasters such as an earthquake or other causes, have delayed and could in the future delay shipments and could have a material adverse effect on the Company. Although there are generally alternate sources for these materials and services, qualification of the alternate sources could cause delays sufficient to have a material adverse effect on the Company. A significant amount of the Company’s third-party subcontractors and suppliers, including third-party foundries that supply silicon wafers, are located in the U.S., Taiwan and China. A significant amount of the Company’s assembly and test operations are conducted by third-party contractors in China, Taiwan and Malaysia.
Note 15: Segment Information
The Company's CEO functions as the chief operating decision maker ("CODM"). The CODM makes operating decisions and assesses performance based on the Company's major product lines, which represent its operating segments. The Company has three operating segments—Signal Integrity, Wireless and Sensing and Protection—that historically have been aggregated into one reportable segment identified as the "Semiconductor Products Group." In the fourth quarter of fiscal year 2022, the Company updated its forecasts and assessed the economic performance of the three operating segments and concluded that Protection is no longer expected to be economically similar to the other operating segments. This is primarily because our projections indicate that the gross margin of products within Protection will not be economically similar to products within the other operating segments. Accordingly, the Company has concluded that Protection should be separately reported as its own reportable segment. This decision resulted in the formation of two reportable segments, including the High-Performance Analog Group, which is comprised of the Signal Integrity and Wireless and Sensing operating segments, and the System Protection Group, which is comprised of the Protection operating segment. All prior year information in the tables below has been revised retrospectively to reflect the change to the Company's reportable segments.
The Company’s assets are commingled among the various operating segments and the CODM does not use asset information in making operating decisions or assessing performance. Therefore, the Company has not included asset information by reportable segment in the segment disclosures below.
Net sales and gross profit by reportable segment were as follows:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Net sales: | | | | | |
High-Performance Analog Group | $ | 537,288 | | | $ | 433,174 | | | $ | 390,300 | |
System Protection Group | 203,570 | | | 161,943 | | | 157,212 | |
Total net sales | $ | 740,858 | | | $ | 595,117 | | | $ | 547,512 | |
Gross profit: | | | | | |
High-Performance Analog Group | $ | 364,594 | | | $ | 283,668 | | | $ | 259,172 | |
System Protection Group | 105,605 | | | 81,631 | | | 78,809 | |
Unallocated costs, including share-based compensation | (4,118) | | | (1,750) | | | (1,297) | |
Total gross profit | $ | 466,081 | | | $ | 363,549 | | | $ | 336,684 | |
Information by Product Line
The Company operates exclusively in the semiconductor industry and primarily within the analog and mixed-signal sector.
The table below provides net sales activity by product line on a comparative basis:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands, except percentages) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Signal Integrity | $ | 291,114 | | | 40 | % | | $ | 255,640 | | | 43 | % | | $ | 222,846 | | | 40 | % |
Wireless and Sensing | 246,174 | | | 33 | % | | 177,534 | | | 30 | % | | 167,454 | | | 31 | % |
Protection | 203,570 | | | 27 | % | | 161,943 | | | 27 | % | | 157,212 | | | 29 | % |
Total net sales | $ | 740,858 | | | 100 | % | | $ | 595,117 | | | 100 | % | | $ | 547,512 | | | 100 | % |
Information by Sales Channel
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Distributor | $ | 647,012 | | | $ | 490,009 | | | $ | 392,582 | |
Direct | 93,846 | | | 105,108 | | | 154,930 | |
| | | | | |
Total net sales | $ | 740,858 | | | $ | 595,117 | | | $ | 547,512 | |
Generally, the Company does not have long-term contracts with its distributors and most distributor agreements can be terminated by either party with short notice. For fiscal year 2022, the Company's largest distributors were based in Asia.
Geographic Information
Net sales activity by geographic region was as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(in thousands, except percentages) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
Asia-Pacific | $ | 583,852 | | | 79 | % | | $ | 474,040 | | | 80 | % | | $ | 421,584 | | | 77 | % |
North America | 90,796 | | | 12 | % | | 71,866 | | | 12 | % | | 76,652 | | | 14 | % |
Europe | 66,210 | | | 9 | % | | 49,211 | | | 8 | % | | 49,276 | | | 9 | % |
| | | | | | | | | | | |
Total net sales | $ | 740,858 | | | 100 | % | | $ | 595,117 | | | 100 | % | | $ | 547,512 | | | 100 | % |
The Company attributes sales to a country based on the ship-to address. The table below summarizes sales activity to countries that represented greater than 10% of total sales for at least one of the periods presented:
| | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
(percentage of total net sales) | January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
China (including Hong Kong) | 60 | % | | 60 | % | | 53 | % |
United States | 10 | % | | 10 | % | | 9 | % |
Total net sales | 70 | % | | 70 | % | | 62 | % |
Although a large percentage of the Company's products is shipped into the Asia-Pacific region, a significant number of the products produced by these customers and incorporating the Company's semiconductor products are then sold outside this region.
Long-lived Assets
The following table summarizes the Company's long-lived assets, which consist of property, plant and equipment, net of accumulated depreciation, classified by location:
| | | | | | | | | | | |
| Balance as of |
(in thousands) | January 30, 2022 | | January 31, 2021 |
United States | $ | 64,927 | | | $ | 61,502 | |
Rest of North America | 37,155 | | | 35,216 | |
Asia and all others | 18,216 | | | 22,877 | |
Europe | 14,642 | | | 11,339 | |
| | | |
Total | $ | 134,940 | | | $ | 130,934 | |
Some of these assets are at locations owned or operated by the Company’s suppliers. The Company has consigned certain equipment to a foundry based in China to support its specialized processes run at the foundry. The Company has also installed its own equipment at some of its packaging and testing subcontractors in order to ensure a certain level of capacity, assuming the subcontractor has ample employees to operate the equipment.
The net book value of equipment and machinery that were consigned to multiple foundries in China was $11.4 million and $15.0 million as of January 30, 2022 and January 31, 2021, respectively. The net book value of equipment and machinery that were consigned to a foundry in Malaysia was $3.3 million and $4.1 million as of January 30, 2022 and January 31, 2021, respectively.
Note 16: Restructuring
From time to time, the Company takes steps to realign the business to focus on high-growth areas, provide customer value and make the Company more efficient. As a result, the Company has occasionally realigned resources and infrastructure. No restructuring expense was recorded in fiscal year 2022. A restructuring recovery of $0.2 million was recorded in fiscal year 2021 and restructuring expense of $2.2 million was recorded in fiscal year 2020.
Restructuring-related liabilities are included in "Accrued liabilities" in the Balance Sheets. Restructuring recoveries related to one-time employee termination benefits were presented in R&D expense and restructuring recoveries related to contract commitments were presented in SG&A expense in the Statements of Income in fiscal year 2021. All restructuring charges were presented in SG&A expense in fiscal year 2020.
Activity related to the restructuring plans is summarized as follows:
| | | | | | | | | | | | | | | | | |
(in thousands) | One-time employee termination benefits | | Contract commitments | | Total |
Balance at January 27, 2019 | $ | 720 | | | $ | 289 | | | $ | 1,009 | |
Charges | 1,483 | | | 683 | | | 2,166 | |
Cash payments | (2,089) | | | (848) | | | (2,937) | |
Balance at January 26, 2020 | 114 | | | 124 | | | 238 | |
Recoveries | (114) | | | (124) | | | (238) | |
| | | | | |
Balance at January 31, 2021 | — | | | — | | | — | |
| | | | | |
| | | | | |
Balance at January 30, 2022 | $ | — | | | $ | — | | | $ | — | |
Note 17: Stock Repurchase Program
The Company maintains a stock repurchase program that was initially approved by its Board of Directors in March 2008. The stock repurchase program does not have an expiration date and the Company’s Board of Directors has authorized expansion of the program over the years. The following table summarizes activity under the program for the fiscal years listed below:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fiscal Year Ended |
| January 30, 2022 | | January 31, 2021 | | January 26, 2020 |
(in thousands, except number of shares) | Shares | | Price Paid | | Shares | | Price Paid | | Shares | | Price Paid |
Shares repurchased under the stock repurchase program | 1,768,772 | | | $ | 129,746 | | | 1,597,104 | | | $ | 71,433 | | | 1,471,703 | | | $ | 70,219 | |
On March 11, 2021, the Company's Board of Directors approved the expansion of the stock repurchase program by an additional $350.0 million. As of January 30, 2022, the Company had repurchased $539.0 million in shares of its common stock under the program since its inception and the remaining authorization under the program was $259.4 million. Under the program, the Company may repurchase its common stock at any time or from time to time, without prior notice, subject to market conditions and other considerations. The Company’s repurchases may be made through Rule 10b5-1 and/or Rule 10b-18 or other trading plans, open market purchases, privately negotiated transactions, block purchases or other transactions. The Company intends to fund repurchases under the program from cash on hand. The Company has no obligation to repurchase any shares under the program and may suspend or discontinue it at any time.
Note 18: Derivatives and Hedging Activities
The Company is exposed to certain risk arising from both its business operations and economic conditions and principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company, on a routine basis and in the normal course of business, experiences expenses denominated in Swiss Franc ("CHF"), Canadian Dollar ("CAD") and Great British Pound ("GBP"). Such expenses expose the Company to exchange rate fluctuations between these foreign currencies and the U.S. Dollar ("USD"). The Company occasionally uses derivative financial instruments, in the form of forward contracts, to mitigate a portion of the risk associated with adverse movements in these foreign currency exchange rates during a twelve month window. Currency forward contracts involve fixing the exchange rate for delivery of a specified amount of foreign currency on a specified date. The Company’s accounting treatment for these instruments is based on whether or not the instruments are designated as a hedging instrument. At January 30, 2022 and January 31, 2021, the Company had no outstanding foreign currency forward contracts.
During the first quarter of fiscal year 2021, the Company entered into an interest rate swap agreement with a three-year term to hedge the variability of interest payments on the first $150.0 million of debt outstanding under the Company's Credit Facility. Interest payments on the first $150.0 million of the Company's debt outstanding under the Credit Facility are now fixed at a rate of 1.9775%, based on the Company's current leverage ratio. The interest rate swap agreement has been designated as a cash flow hedge and unrealized gains or losses, net of tax, are recorded as a component of "Accumulated Other Comprehensive Income or Loss" ("AOCI") in the Balance Sheets. As the various settlements are made on a monthly basis, the realized gain or loss on the settlements are recorded in "Interest expense" in the Statements of Income. Realized losses on the interest rate swap agreement totaled $0.9 million and $0.5 million for fiscal years 2022 and 2021, respectively.
The fair values of the Company's derivative instruments that qualify as cash flow hedges in the Balance Sheets were as follows:
| | | | | | | | | | | | | | |
| | Balance as of |
(in thousands) | | January 30, 2022 | | January 31, 2021 |
Interest rate swap agreement | | $ | 62 | | | $ | — | |
Total other current assets | | $ | 62 | | | $ | — | |
| | | | |
Interest rate swap agreement | | $ | 167 | | | $ | — | |
Total other long-term assets | | $ | 167 | | | $ | — | |
| | | | |
| | | | |
Interest rate swap agreement | | $ | — | | | $ | 849 | |
| | | | |
Total accrued liabilities | | $ | — | | | $ | 849 | |
| | | | |
| | | | |
Interest rate swap agreement | | $ | — | | | $ | 933 | |
Total other long-term liabilities | | $ | — | | | $ | 933 | |
During the fourth quarter of fiscal year 2021, the Company entered into an economic hedge program that uses total return swap contracts to hedge the market risk associated with the unfunded portion of the Company's deferred compensation liability. The total return swap contracts generally have a duration of one month and are rebalanced and re-hedged at the end of each monthly term. While the total returns swap contracts are treated as economic hedges, the Company has not designated them as hedges for accounting purposes. The total return swap contracts are measured at fair value and recognized in the Balance Sheets in "Accrued Liabilities" if the instruments are in a loss position and in "Other Current Assets" if the instruments are in a gain position. Unrealized gains and losses, as well as realized gains and losses for settlements, on the total return swap contracts are recognized in "SG&A expense" in the Statements of Income. As of January 30, 2022, the notional value of the total return swap contracts was $7.8 million and the fair value resulted in a liability balance of $0.3 million. As of January 31, 2021, the notional value of the total return swap contracts was $11.9 million and the fair value resulted in a liability balance of $0.2 million. Net gains recognized in earnings on the total return swap contracts were $1.5 million and $0.3 million for fiscal years 2022 and 2021, respectively.